Elsevier

Cytokine

Volume 127, March 2020, 154965
Cytokine

IL-33 and ST2 as predictors of disease severity in children with viral acute lower respiratory infection

https://doi.org/10.1016/j.cyto.2019.154965Get rights and content

Highlights

  • An exacerbated activation of IL-33/ST2 axis was associated with severity of viral ALRI.

  • Detectable NPA IL-33 and sST-2 levels were risk factors for mechanical ventilation.

  • An increment in NPA sST2 levels was associated with longer hospital length of stay.

  • A systemic increase in IL-33 concentrations was associated with milder disease.

Abstract

Background

Mechanisms influencing severity of acute lower respiratory infection (ALRI) in children are not established. We aimed to assess the role of inflammatory markers and respiratory viruses in ALRI severity.

Methods

Concentrations of interleukin(IL)-33, soluble suppression of tumorigenicity (sST)2, IL-1ß, tumor necrosis factor α, IL-4, IL-6 and IL- 8 and types of respiratory viruses were evaluated in children at the first and fifth days after hospital admission. Disease severity was defined as need for mechanical ventilation.

Results

Seventy-nine children <5 years-old were included; 33(41.8%) received mechanical ventilation. No associations between virus type, viral load or co-detections and severity of disease were observed. Detection of IL-33 and sST2 in nasopharyngeal aspirates (NPA) on admission were associated with higher risk for mechanical ventilation (RR = 2.89 and RR = 4.57, respectively). IL-6 and IL-8 concentrations were higher on Day 5 in mechanically ventilated children. IL-6 NPA concentrations decreased from Day 1 to Day 5 in children who did not receive mechanical ventilation. Increase in sST2 NPA concentrations from Day 1 to Day 5 was associated with longer hospital length of stay (p < 0.01).

Conclusions

An exacerbated local activation of the IL-33/ST2 axis and persistently high sST2 concentrations over time were associated with severity of viral ALRI in children.

Keywords

Acute lower respiratory infection
Inflammatory cytokines
Interleukin 33
Soluble suppression of tumorigenicity 2
Respiratory viruses

Cited by (0)

View Abstract